Pharma Markets

Europe Type 1 Diabetes Market and Competitive Landscape

By Fore Pharma | Published Date: June 7, 2020 | On-Demand Data

The latest research from Fore Pharma, Europe Type 1 Diabetes Market and Competitive Landscape – 2020, provides comprehensive insights into Type 1 Diabetes pipeline, epidemiology, market valuations, drug sales, market forecast, drug forecasts, and market shares. This research analyzes and forecast Type 1 Diabetes market size and drug sales. It also provides insights into Type 1 Diabetes epidemiology and late stage pipeline.

This research covers the following – Type 1 Diabetes treatment options, Type 1 Diabetes late stage clinical trials pipeline, Type 1 Diabetes prevalence by countries, Type 1 Diabetes market size and forecast by countries, key market events and trends, drug sales and forecast by countries, and market shares by countries. The research scope includes the countries Germany, France, Italy, Spain, UK, Europe (EU5 Countries).

Research Scope:

– Countries: Germany, France, Italy, Spain, UK, Europe
– Type 1 Diabetes pipeline: Find out drugs in clinical trials for Type 1 Diabetes by development phase 3, phase 2, and phase 1, by pharmacological class and company
– Type 1 Diabetes epidemiology: Find out number of patients diagnosed (prevalence) with Type 1 Diabetes by countries
– Type 1 Diabetes drugs: Identify key drugs marketed and prescribed for Type 1 Diabetes by countries, including trade name, molecule name, and company
– Type 1 Diabetes drugs sales: Find out the sales value for Type 1 Diabetes drugs by countries
– Type 1 Diabetes market valuations: Find out the market size for Type 1 Diabetes drugs in 2019 by countries. Find out how the market advanced from 2016 and forecast to 2025
– Type 1 Diabetes drugs market share: Find out the market shares for key drugs by countries

Benefits of this Research: The research helps executives to

– Evaluate commercial market opportunities for Type 1 Diabetes drugs
– Synthesize insights for business development & licensing
– Track market size, competitor drug sales, market shares in Type 1 Diabetes market
– Develop in-depth knowledge of competition and markets
– Analyze Type 1 Diabetes drug sales data to update your brand planning trackers
– Develop tactics and strategies to take advantage of opportunities in the market
– Track Market Events and Trends and analyze key events in Type 1 Diabetes market
– Develop forecast models, healthcare frameworks, or economic models
– Answer key business questions; supports decision making in R&D to long term marketing strategies

Table of Contents


1. Type 1 Diabetes Treatment Options
2. Type 1 Diabetes Pipeline Insights
2.1. Type 1 Diabetes Phase 3 Clinical Trials
2.2. Type 1 Diabetes Phase 2 Clinical Trials
2.3. Type 1 Diabetes Phase 1 Clinical Trials
3. Type 1 Diabetes Epidemiology Analysis by Countries
4. Germany Type 1 Diabetes Market Insights
4.1. Marketed Drugs for Type 1 Diabetes in Germany
4.2. Germany Type 1 Diabetes Market Size & Forecast
4.3. Germany Type 1 Diabetes Drugs Sales Forecast
4.4. Germany Type 1 Diabetes Market Share Analysis
5. France Type 1 Diabetes Market Insights
5.1. Marketed Drugs for Type 1 Diabetes in France
5.2. France Type 1 Diabetes Market Size & Forecast
5.3. France Type 1 Diabetes Product Sales Forecast
5.4. France Type 1 Diabetes Market Share Analysis
6. Italy Type 1 Diabetes Market Insights
6.1. Marketed Drugs for Type 1 Diabetes in Italy
6.2. Italy Type 1 Diabetes Market Size & Forecast
6.3. Italy Type 1 Diabetes Product Sales Forecast
6.4. Italy Type 1 Diabetes Market Share Analysis
7. Spain Type 1 Diabetes Market Insights
7.1. Marketed Drugs for Type 1 Diabetes in Spain
7.2. Spain Type 1 Diabetes Market Size & Forecast
7.3. Spain Type 1 Diabetes Product Sales Forecast
7.4. Spain Type 1 Diabetes Market Share Analysis
8. UK Type 1 Diabetes Market Insights
8.1. Marketed Drugs for Type 1 Diabetes in UK
8.2. UK Type 1 Diabetes Market Size & Forecast
8.3. UK Type 1 Diabetes Product Sales Forecast
8.4. UK Type 1 Diabetes Market Share Analysis
9. Europe Type 1 Diabetes Market Insights
9.1. Europe Type 1 Diabetes Market Size & Forecast
9.2. Europe Type 1 Diabetes Product Sales Forecast
9.3. Europe Type 1 Diabetes Market Share Analysis
10. Research Methodology

List of Tables


1: Type 1 Diabetes Phase 3 Clinical Trials, Global, 2020
2: Type 1 Diabetes Phase 2 Clinical Trials, Global, 2020
3: Type 1 Diabetes Phase 1 Clinical Trials, Global, 2020
4: Type 1 Diabetes Prevalence by Countries, 2016 – 2025
5: Marketed Drugs for Type 1 Diabetes in Germany, 2019
6: Germany Type 1 Diabetes Market Size & Forecast ($mn), 2016 – 2025
7: Germany Type 1 Diabetes Product Sales ($mn), 2016 – 2025
8: Germany Type 1 Diabetes Market Events and Trends, 2016 – 2025
9: Marketed Drugs for Type 1 Diabetes in France, 2019
10: France Type 1 Diabetes Market Size & Forecast ($mn), 2016 – 2025
11: France Type 1 Diabetes Product Sales ($mn), 2016 – 2025
12: France Type 1 Diabetes Market Events and Trends, 2016 – 2025
13: Marketed Drugs for Type 1 Diabetes in Italy, 2019
14: Italy Type 1 Diabetes Market Size & Forecast ($mn), 2016 – 2025
15: Italy Type 1 Diabetes Product Sales ($mn), 2016 – 2025
16: Italy Type 1 Diabetes Market Events and Trends, 2016 – 2025
17: Marketed Drugs for Type 1 Diabetes in Spain, 2019
18: Spain Type 1 Diabetes Market Size & Forecast ($mn), 2016 – 2025
19: Spain Type 1 Diabetes Product Sales ($mn), 2016 – 2025
20: Spain Type 1 Diabetes Market Events and Trends, 2016 – 2025
21: Marketed Drugs for Type 1 Diabetes in UK, 2019
22: UK Type 1 Diabetes Market Size & Forecast ($mn), 2016 – 2025
23: UK Type 1 Diabetes Product Sales ($mn), 2016 – 2025
24: UK Type 1 Diabetes Market Events and Trends, 2016 – 2025
25: Europe Type 1 Diabetes Market Size & Forecast ($mn), 2016 – 2025
26: Europe Type 1 Diabetes Product Sales ($mn), 2016 – 2025

List of Figures


1: Type 1 Diabetes Pipeline by Phase (%), Global, 2020
2: Type 1 Diabetes Prevalence by Countries, 2016 – 2025
3: Germany Type 1 Diabetes Market Size ($mn), 2016 – 2025
4: Germany Type 1 Diabetes Product Sales ($mn), 2016 – 2025
5: Germany Type 1 Diabetes Market Share by Drugs (%), 2019
6: Germany Type 1 Diabetes Market – Future Market Share (%), 2025
7: France Type 1 Diabetes Market Size ($mn), 2016 – 2025
8: France Type 1 Diabetes Product Sales ($mn), 2016 – 2025
9: France Type 1 Diabetes Market Share by Drugs (%), 2019
10: France Type 1 Diabetes Market – Future Market Share (%), 2025
11: Italy Type 1 Diabetes Market Size ($mn), 2016 – 2025
12: Italy Type 1 Diabetes Product Sales ($mn), 2016 – 2025
13: Italy Type 1 Diabetes Market Share by Drugs (%), 2019
14: Italy Type 1 Diabetes Market – Future Market Share (%), 2025
15: Spain Type 1 Diabetes Market Size ($mn), 2016 – 2025
16: Spain Type 1 Diabetes Product Sales ($mn), 2016 – 2025
17: Spain Type 1 Diabetes Market Share by Drugs (%), 2019
18: Spain Type 1 Diabetes Market – Future Market Share (%), 2025
19: UK Type 1 Diabetes Market Size ($mn), 2016 – 2025
20: UK Type 1 Diabetes Product Sales ($mn), 2016 – 2025
21: UK Type 1 Diabetes Market Share by Drugs (%), 2019
22: UK Type 1 Diabetes Market – Future Market Share (%), 2025
23: Europe Type 1 Diabetes Market Size ($mn), 2016 – 2025
24: Europe Type 1 Diabetes Product Sales ($mn), 2016 – 2025
25: Europe Type 1 Diabetes Market Share by Drugs (%), 2019
26: Europe Type 1 Diabetes Market – Future Market Share (%), 2025

Format


Dispatch format is XLSX.

Purchase Checkout Added to cart
face
  • Contact Nick
  •  Email
  •  Contact
  • I was looking for specific epidemiology and utilization data for our emerging therapy situation analysis. It was time sensitive. Your team helped me with the right data and methodologies. Thank you very much.
    - Director, Big Pharma

    About

    • About us
    • Research Store
    • Research Store
    • News
    • Contact

    Trusted By
    Top Companies